semaglutide stock symbol Novo Nordisk rises after Wegovy recommended by UK's drug price watchdog NVO Stock: Should You Buy

Result: More effective gastric pH control, better symptom relief, and improved patient outcomes To view or add a comment, sign in The Hidden Side of GLP-1 & GIP Therapies Semaglutide and Tirzepatide have redefined obesity and diabetes management delivering life-changing results in weight loss, glycemic control, and cardiometabolic health

I stand behind it

Chest pain is not listed as a common side effect of semaglutide in clinical trials, though cardiovascular symptoms warrant careful medical evaluation

When you pause these medications, you may experience a resurgence of symptoms, which can be detrimental to your health

It is considered a controlled substance that can be addictive and carries the risk of withdrawal symptoms and potential side effects such as a racing or irregular heartbeat